Neuropeptide Y and derivates are not ready for prime time in prostate cancer early detection

Neuropeptide Y (NPY) and related peptides have been proposed as promising biomarkers for the diagnosis of prostate cancer by previous immunoassays and immunohistochemical studies. In this study, we evaluated the additional value of NPY and related peptides compared with prostate-specific antigen (PS...

Descripció completa

Dades bibliogràfiques
Autors principals: Maurer, J, Eugster, PJ, Collins, K, Vocat, C, Oke, J, Nicholson, B, Rakauskas, A, Grouzmann, E, Valerio, M
Format: Journal article
Idioma:English
Publicat: Elsevier 2024

Ítems similars